Four years ago, Exact Sciences was roadkill. The company, based in greater Boston at the time, had been experimenting with molecular diagnostic technologie
Try Scoop.it for Free
Build engaged audiences through publishing by curation.
Sign up with Facebook Sign up with Twitter
I don't have a Facebook, a Twitter or a LinkedIn account
Start a free trial of Scoop.it Business
Already have an account: Login
 Your new post is loading...
Scoop.it!
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
No comment yet.
Sign up to comment
Scoop.it!
Eurofins Mediogenomix has licensed co-exclusive rights to Orion Diagnostica's strand invasion-based amplification (SIBA) technology, the firms announced today... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
L'année 2013 marque à la fois les 60 ans de la découverte de la structure moléculaire de l'ADN par Watson et Crick ainsi que les 10 ans de l'achèvement du Projet Génome Humain. Le 19 novembre dernier, la Food and Drug Administration (FDA) a autorisé pour la première fois la mise sur le marché de 4 outils de séquençage à haut débit de la société Illumina, basée à San Diego : un appareil de séquençage Illuminex MiSeqDx, un kit universel de réactifs, et deux tests de dépistage pour la mucoviscidose.... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Natera today announced it has reached a deal with DiagCor to launch Natera's non-invasive prenatal screening test in Hong Kong. DiagCor is based in Hong Kong and provides molecular diagnostic testing to doctors and healthcare professionals in the region... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
MedTech Europe has just released a brand new dynamic infographic on the role of medical devices for healthcare. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Epigenomics today said that it a French supplementary insurance provider will provide coverage for the firm's Septin9 test for early detection of colorectal cancer. The Berlin, Germany-based molecular diagnostics firm said that Mutuelle d’Assurance du Corps de Santé Français (MACSF) will reimburse €50 ($68.80) for the test. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
L'Usine Nouvelle Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
La société de diagnostic in vitro ATEROVAX lève 1,5 M€ FUSACQ Un nouveau partenariat conclu début 2013 avec Randox Medical, leader dans le diagnostic des maladies cardiovasculaires, va assurer une diffusion globale du test, sous un format destiné... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Rosetta Genomics, a provider of microRNA-based molecular diagnostics, has obtained a conditional approval from the New York State Department of Health...This approval allows the company to offer its Rosetta Kidney Cancer Test in all 50 US states. In making the assay available pending final approval... Rosetta Kidney Cancer Test is a microRNA-based assay which accurately classifies the four most common kidney tumors, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC and the benign oncocytoma...with its high level of accuracy, Rosetta Kidney Cancer Test is a microRNA-based assay can be an important aid to physicians to ensure that the right medical intervention is given to the right patient at the right time, which is what personalized medicine is all about. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Life Technologies has become a partner in two research projects, the Saudi Human Genome Program and the International Barcode of Life (iBOL) project, the company said this week. The projects will employ the firm's Ion Proton, capillary electrophoresis, and PGM sequencing technologies... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
bioMérieux, acteur mondial du diagnostic in vitro, annonce qu'elle franchit une nouvelle étape dans le déploiement de sa solution d’automatisation complète destinée aux laboratoires de biologie moléculaire centralisés ou de référence. bioMérieux a sélectionné les thermocycleurs 7500 de Life Technologies (Applied Biosystems® 7500, 7500 Fast et 7500 Fast Dx) comme sa gamme phare de thermocycleurs et la place au coeur de sa solution d’automatisation modulaire. bioMérieux a pour objectif de consolider davantage sa position d’acteur majeur du diagnostic des maladies infectieuses en capitalisant sur sa franchise « Biologie Moléculaire » pour compléter les méthodes de diagnostic classiques, notamment pour les situations d’urgence et les soins intensifs. La franchise de bioMérieux en biologie moléculaire reposera sur deux piliers : une solution d’automatisation complète pour les laboratoires centralisés ou de référence et FilmArray®, le système intégré de BioFire et son approche syndromique des maladies infectieuses. La solution d’automatisation complète de bioMérieux destinée aux laboratoires centralisés ou de référence comprendra trois modules, allant de la prise en charge des échantillons jusqu’au rendu des résultats : - la plateforme de purification des échantillons, NucliSENS® easyMAG® de bioMérieux dont la position significative sur le marché (avec plus de 1 200 instruments installés au 30 septembre 2013) sera encore renforcée avec le lancement prochain d’une nouvelle génération ; - easySTREAM™, un système de préparation automatisée des échantillons pour les tests PCR, dont le lancement est en cours ; - les thermocycleurs Applied Biosystems® de PCR en temps réel de Life Technologies ; - NucliSentral®, un middleware pour connecter toutes les plateformes. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Roche receives FDA clearance to use additional specimen types for chlamydia and gonorrhea test PLEASANTON, Calif., Dec. 4, 2013 /PRNewswire/ -- Roche Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Becton Dickinson today announced that it has received US Food and Drug Administration clearance to market its new assay for detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from nasal swabs... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
Scoop.it!
Lineagen today announced it completed a Series C financing round that raised $3.5 million. The Salt Lake City-based molecular diagnostic firm also said that it received multiple term sheets for multimillion dollar senior secured debt facilities, including one that it intends to close as part of the Series C financing. It also announced it is converting $12.6 million in outstanding promissory notes into shares of Series B preferred stock... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Veracyte said after the close of the market on Monday that Cigna has issued a positive coverage decision for the Afirma Gene Expression Classifier test... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Siemens: développera des tests de diagnostic avec Pfizer. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Siemens Healthcare Diagnostics today said that it has signed a master collaboration agreement with Pfizer for the development of companion diagnostics for certain undisclosed therapeutic products in the drug giant's pipeline.... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
L'année 2013 marque à la fois les 60 ans de la découverte de la structure moléculaire de l'ADN par Watson et Crick ainsi que les 10 ans de l'achèvement du Projet Génome Humain. Le 19 novembre dernier, la Food and Drug Administration (FDA) a autorisé pour la première fois la mise sur le marché de 4 outils de séquençage à haut débit de la société Illumina, basée à San Diego : un appareil de séquençage Illuminex MiSeqDx, un kit universel de réactifs, et deux tests de dépistage pour la mucoviscidose. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
A research partnership in Saudi Arabia has launched a national effort to study the genetic basis of disease. Headed by researchers from the King Abdulaziz City for Science and Technology and Life Technologies, the program will create a DNA database to help fuel the development of personalized medicine. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
BioAgilytix Labs, a leading provider of contract bioanalytical testing services, today announced that Jim Datin has joined the company as Chief Executive Officer. Jim is a seasoned executive with significant experience in the Pharmaceutical, Life Sciences and Biotech industries. .. Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
NanoString Technologies said ...that several US clinical laboratories will adopt the company's breast cancer assay starting in the first quarter of 2014. Among those who will offer NanoString's Prosigna Breast Cancer Prognostic Gene Signature Assay are Arup Laboratories, Laboratory Corporation of America, and Quest Diagnostics. Additionally, the University of Alabama at Birmingham Comprehensive Cancer Center and the University of North Carolina Lineberger Comprehensive Cancer Center "will be among the initial wave of facilities to offer the Prosigna Assay in 2014," NanoString said.
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Co-Diagnostics said recently that certain real-time PCR technology has been transferred to the company from DNA Logix... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
Sequenom, Inc, une entreprise de sciences de la vie qui propose des solutions innovantes de test et d'analyse génétique, a annoncé que le Laboratoire Cerba avait mis à disposition son test prénatal non invasif (TPNI) agréé destiné aux professionnels de santé et à leurs patients en France, en Belgique, au Luxembourg et certaines régions du Moyen-Orient et d'Afrique... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
RHONE. bioMérieux fête ses 50 ans à Lyon Le Progrès La société bioMérieux, créée en 1963 à Marcy-l'Etoile (Rhône), célèbre vendredi ses 50 ans en présence de plusieurs centaines de ses salariés réunis pour une fête interne organisée à la Halle... Delete the scoop?
Are you sure you want to delete this scoop?
Yes
Scoop.it!
(AOF) - bioMérieux a franchi une nouvelle étape dans le déploiement de sa solution d'automatisation complète destinée aux laboratoires de biologie Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
